Robert L White1,2, Meghan C Campbell1,3, Dake Yang4, William Shannon4, Abraham Z Snyder1,3, Joel S Perlmutter1,3,5,6,7. 1. Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA. 2. John Cochrane VA Medical Center, Neurology Section, St. Louis, Missouri, USA. 3. Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA. 4. BioRankings, St. Louis, Missouri, USA. 5. Department of Neuroscience, Washington University School of Medicine, St. Louis, Missouri, USA. 6. Program in Occupational Therapy, Washington University School of Medicine, St. Louis, Missouri, USA. 7. Program in Physical Therapy, Washington University School of Medicine, St. Louis, Missouri, USA.
Abstract
OBJECTIVE: The objective of this study was to investigate the effects of levodopa on functional brain networks in Parkinson's disease. METHODS: We acquired resting state functional magnetic resonance imaging in 30 drug-naïve participants with Parkinson's disease and 20 age-matched healthy controls. Each participant was studied following administration of a single oral dose of either levodopa or placebo in a randomized, double-blind, crossover design. RESULTS: The greatest observed differences in functional connectivity were between Parkinson's disease versus control participants, independent of pharmacologic intervention. By contrast, the effects of levodopa were much smaller and detectable only in the Parkinson's disease group. Moreover, although levodopa administration in the Parkinson's disease group measurably improved motor performance, it did not increase the similarity of functional connectivity in Parkinson's disease to the control group. CONCLUSIONS: We found that a single, small dose of levodopa did not normalize functional connectivity in drug-naïve Parkinson's disease.
RCT Entities:
OBJECTIVE: The objective of this study was to investigate the effects of levodopa on functional brain networks in Parkinson's disease. METHODS: We acquired resting state functional magnetic resonance imaging in 30 drug-naïve participants with Parkinson's disease and 20 age-matched healthy controls. Each participant was studied following administration of a single oral dose of either levodopa or placebo in a randomized, double-blind, crossover design. RESULTS: The greatest observed differences in functional connectivity were between Parkinson's disease versus control participants, independent of pharmacologic intervention. By contrast, the effects of levodopa were much smaller and detectable only in the Parkinson's disease group. Moreover, although levodopa administration in the Parkinson's disease group measurably improved motor performance, it did not increase the similarity of functional connectivity in Parkinson's disease to the control group. CONCLUSIONS: We found that a single, small dose of levodopa did not normalize functional connectivity in drug-naïve Parkinson's disease.
Authors: Patricio S La Rosa; Terrence L Brooks; Elena Deych; Berkley Shands; Fred Prior; Linda J Larson-Prior; William D Shannon Journal: Stat Med Date: 2015-11-25 Impact factor: 2.373
Authors: Deanna J Greene; Timothy O Laumann; Joseph W Dubis; S Katie Ihnen; Maital Neta; Jonathan D Power; John R Pruett; Kevin J Black; Bradley L Schlaggar Journal: J Neurosci Date: 2014-04-23 Impact factor: 6.167
Authors: Evan M Gordon; Timothy O Laumann; Babatunde Adeyemo; Jeremy F Huckins; William M Kelley; Steven E Petersen Journal: Cereb Cortex Date: 2014-10-14 Impact factor: 5.357
Authors: T Hershey; K J Black; J L Carl; L McGee-Minnich; A Z Snyder; J S Perlmutter Journal: J Neurol Neurosurg Psychiatry Date: 2003-07 Impact factor: 10.154
Authors: Patricio S La Rosa; Berkley Shands; Elena Deych; Yanjiao Zhou; Erica Sodergren; George Weinstock; William D Shannon Journal: PLoS One Date: 2012-11-09 Impact factor: 3.240
Authors: John R Younce; Meghan C Campbell; Tamara Hershey; Aaron B Tanenbaum; Mikhail Milchenko; Mwiza Ushe; Morvarid Karimi; Samer D Tabbal; Albert E Kim; Abraham Z Snyder; Joel S Perlmutter; Scott A Norris Journal: Mov Disord Date: 2020-11-19 Impact factor: 10.338
Authors: Adam P Horin; Peter S Myers; Kristen A Pickett; Gammon M Earhart; Meghan C Campbell Journal: Behav Brain Res Date: 2021-06-02 Impact factor: 3.352
Authors: Abraham Z Snyder; Tomoyuki Nishino; Joshua S Shimony; Eric J Lenze; Julie Loebach Wetherell; Michelle Voegtle; J Philip Miller; Michael D Yingling; Daniel Marcus; Jenny Gurney; Jerrel Rutlin; Drew Scott; Lisa Eyler; Deanna Barch Journal: Front Neurosci Date: 2022-03-18 Impact factor: 4.677
Authors: Arefeh Sherafati; Abraham Z Snyder; Adam T Eggebrecht; Karla M Bergonzi; Tracy M Burns-Yocum; Heather M Lugar; Silvina L Ferradal; Amy Robichaux-Viehoever; Christopher D Smyser; Ben J Palanca; Tamara Hershey; Joseph P Culver Journal: Hum Brain Mapp Date: 2020-07-10 Impact factor: 5.038